rotenone has been researched along with Ureteral Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, G; Huang, S; Jia, Z; Sun, Y; Zhang, A; Zhang, Y; Zhao, D | 1 |
| Ding, G; Huang, S; Jia, Z; Sun, Y; Zhang, A; Zhang, Y | 1 |
2 other study(ies) available for rotenone and Ureteral Obstruction
| Article | Year |
|---|---|
Rotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathy.
Topics: Animals; Fibrosis; Immunohistochemistry; Inflammation; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Rotenone; Ureteral Obstruction | 2014 |
Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCĪ± in Obstructive Kidney Disease.
Topics: Angiotensin II; Animals; Dinoprostone; Electron Transport Complex I; Epithelial Sodium Channels; Gene Expression Regulation; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mitochondria; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase Type II; Rotenone; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Ureteral Obstruction | 2015 |